Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesNew GSK Product Should Help Alleviate Hib Vaccine Shortage. FDA Approves Hiberix for Booster Dose
American Family Physician, 08/28/09
The nation's supply of Hib vaccine should see a much–needed upsurge in the coming weeks, thanks to the Aug. 19 FDA approval of GlaxoSmithKline's Hiberix as a booster dose for children ages 15 months to 4 years. The CDC – in consultation with ACIP, the AAFP and the American Academy of Pediatrics – recommended June 25 that physicians reinstate the Hib booster dose for children ages 12–15 months who have completed the three–dose primary series. A booster dose also should be given to older children (i.e., those as old as 59 months) in whom the booster was deferred during their next routinely scheduled office visit. A nationwide Hib vaccine shortage started in 2007, when Merck & Co. Inc. recalled a dozen lots of Hib–containing vaccine and later suspended production of its Hib–containing vaccine products. Merck said on its Web site Aug. 24 that it anticipates its monovalent Hib vaccine PedvaxHIB will return to the U.S. market by the first quarter of 2010, with the possibility of limited availability in the fourth quarter of 2009. Despite manufacturer Sanofi Pasteur's attempts to fill the Hib vaccine gap with two Hib–containing vaccine products, the CDC began receiving case reports of invasive Hib disease in children last year, leading the agency to remind physicians of the need to complete the primary series using whatever vaccine was available, including combination products.
Related Articles
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes
Clinical Microbiology and Infection, 11/11/09
Relevance Score: 69%
Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: Systematic review of randomized controlled trials and quasi-randomized controlled trials
Clinical Therapeutics, 10/16/09
Relevance Score: 69%
H1N1 vaccine shortage leaves doctors managing crowds, anxieties
American Medical News, 11/06/09
Relevance Score: 66%
Modern Trends in Mortality From Meningococcal Disease in Australia
The Pediatric Infectious Disease Journal, 10/29/09
Relevance Score: 66%
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 49%
Today in Peds Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
BMC Infectious Diseases, 12/03/09
Children caring for their caregivers: exploring the caring arrangements in households affected by AIDS in Western Kenya
AIDS Care, 12/03/09
Relative Impact of Influenza and Respiratory Syncytial Virus in Young Children
Pediatrics, 12/02/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Patterns of Influenza Vaccination among Medical Students
Infection Control and Hospital Epidemiology, 12/03/09
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years : The Lancet
The Lancet - Early Online Publication, 12/03/09
Update on Rotarix: an oral human rotavirus vaccine
Expert Review of Vaccines, 12/02/09
Article Search
Sponsor